tradingkey.logo
tradingkey.logo
Search

Tempest Therapeutics Inc

TPST
Add to Watchlist
1.160USD
+0.405+53.64%
Market hours 09/16, 09:54ET
18.54MMarket Cap
0.04P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+53.64%

5 Days

+17.53%

1 Month

+14.29%

6 Months

-48.67%

Year to Date

-59.58%

1 Year

-88.31%

Key Figures

1.080Open
1.200High
785.25KVolume
0.04P/E TTM
LossP/E Dynamic
--Dividend TTM
4.91%Turnover Ratio
0.755Prev. Close
1.030Low
881.56KTurnover
LossP/E Static
-17.01P/B
0.00%Div Yield TTM
-200.87%ROA
12.23052wk High
2.28Volume Ratio
-41.84MNet Profit
15.98MShares
32.2064EPS TTM
-1.78Beta
-721.00%ROE
0.74352wk Low
22.52%Amplitude
--Gross Margin
18.54MMarket Cap
1.14Reward/Risk
6.46%Risk Rate
More news coming soon, stay tuned...

Tempest Therapeutics Inc's Score

0.04vs previous score
Forecast8.00
Financial Health6.98
Technical5.38
Valuation Dimensions9.29
Institutional Confidence3.00
Risk Assessment2.61

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
11.000Target Price
+1255.18%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy00000000
Buy11111111
Hold00000000
Sell00000000
Strong Sell00000000

Tempest Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Neutral

Summary

Neutral

Moving Average

Buy

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.34/-0.30
Revenue / Forecast
--/0.00

Tempest Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolTPST
Number of employees24
CountryUnited States of America

Ownership

ShareholdersProportion
Angel (Matthew)35.34%
Lotus Capital Limited23.92%
Versant Ventures1.88%
Vanguard Capital Management, LLC1.63%
Shareholder TypesProportion
Individual Investor35.37%
Investment Advisor26.67%
Venture Capital1.88%
Investment Advisor/Hedge Fund1.74%

FAQs

What is the current price of Tempest Therapeutics Inc (TPST)?

The current price of Tempest Therapeutics Inc (TPST) is 0.76.

What is the symbol of Tempest Therapeutics Inc?

The ticker symbol of Tempest Therapeutics Inc is TPST.

What is the 52-week high of Tempest Therapeutics Inc?

The 52-week high of Tempest Therapeutics Inc is 12.23.

What is the 52-week low of Tempest Therapeutics Inc?

The 52-week low of Tempest Therapeutics Inc is 0.74.

What is the market capitalization of Tempest Therapeutics Inc?

The market capitalization of Tempest Therapeutics Inc is 11.97M.

Is Tempest Therapeutics Inc (TPST) currently rated as Buy, Hold, or Sell?

According to analysts, Tempest Therapeutics Inc (TPST) has an overall rating of Buy, with a price target of 11.00.

What is the Earnings Per Share (EPS TTM) of Tempest Therapeutics Inc (TPST)?

The Earnings Per Share (EPS TTM) of Tempest Therapeutics Inc (TPST) is 32.21.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.